Cargando…

The burden of Burkitt lymphoma in Africa

BACKGROUND: Burkitt lymphoma (BL) is a relatively common cancer of childhood in tropical Africa, although its precise incidence and continent-wide geographic distribution have not been previously systematically studied. METHODS: Using the methods employed to produce national estimates of cancer inci...

Descripción completa

Detalles Bibliográficos
Autores principales: Hämmerl, Lucia, Colombet, Murielle, Rochford, Rosemary, Ogwang, David Martin, Parkin, Donald Maxwell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670145/
https://www.ncbi.nlm.nih.gov/pubmed/31388351
http://dx.doi.org/10.1186/s13027-019-0236-7
_version_ 1783440502475980800
author Hämmerl, Lucia
Colombet, Murielle
Rochford, Rosemary
Ogwang, David Martin
Parkin, Donald Maxwell
author_facet Hämmerl, Lucia
Colombet, Murielle
Rochford, Rosemary
Ogwang, David Martin
Parkin, Donald Maxwell
author_sort Hämmerl, Lucia
collection PubMed
description BACKGROUND: Burkitt lymphoma (BL) is a relatively common cancer of childhood in tropical Africa, although its precise incidence and continent-wide geographic distribution have not been previously systematically studied. METHODS: Using the methods employed to produce national estimates of cancer incidence for the “Globocan” series of the International Agency for Research on Cancer, along with detailed information on cancer incidence by histological subtype from cancer registries in Africa, we estimate the numbers and rates of incidence by sex, age group, country and region of Africa. RESULTS: We estimate that the number of new cases that occurred in 2018 to be about 3900, two thirds in males, and 81% in children aged 0–14. On a national basis, the geographic distribution of incidence rates among children in sub-Saharan Africa resembles that of the prevalence of infection with Falciparum malaria. An estimated 81% of cases are associated with infection with Epstein Barr virus (EBV). CONCLUSIONS: BL comprises almost 50% of childhood of non-Hodgkin lymphoma in Africa, almost all of which are associated with EBV, with the geographic distribution – at least in sub Saharan Africa - mediated by infection with malaria.
format Online
Article
Text
id pubmed-6670145
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66701452019-08-06 The burden of Burkitt lymphoma in Africa Hämmerl, Lucia Colombet, Murielle Rochford, Rosemary Ogwang, David Martin Parkin, Donald Maxwell Infect Agent Cancer Research Article BACKGROUND: Burkitt lymphoma (BL) is a relatively common cancer of childhood in tropical Africa, although its precise incidence and continent-wide geographic distribution have not been previously systematically studied. METHODS: Using the methods employed to produce national estimates of cancer incidence for the “Globocan” series of the International Agency for Research on Cancer, along with detailed information on cancer incidence by histological subtype from cancer registries in Africa, we estimate the numbers and rates of incidence by sex, age group, country and region of Africa. RESULTS: We estimate that the number of new cases that occurred in 2018 to be about 3900, two thirds in males, and 81% in children aged 0–14. On a national basis, the geographic distribution of incidence rates among children in sub-Saharan Africa resembles that of the prevalence of infection with Falciparum malaria. An estimated 81% of cases are associated with infection with Epstein Barr virus (EBV). CONCLUSIONS: BL comprises almost 50% of childhood of non-Hodgkin lymphoma in Africa, almost all of which are associated with EBV, with the geographic distribution – at least in sub Saharan Africa - mediated by infection with malaria. BioMed Central 2019-08-01 /pmc/articles/PMC6670145/ /pubmed/31388351 http://dx.doi.org/10.1186/s13027-019-0236-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hämmerl, Lucia
Colombet, Murielle
Rochford, Rosemary
Ogwang, David Martin
Parkin, Donald Maxwell
The burden of Burkitt lymphoma in Africa
title The burden of Burkitt lymphoma in Africa
title_full The burden of Burkitt lymphoma in Africa
title_fullStr The burden of Burkitt lymphoma in Africa
title_full_unstemmed The burden of Burkitt lymphoma in Africa
title_short The burden of Burkitt lymphoma in Africa
title_sort burden of burkitt lymphoma in africa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670145/
https://www.ncbi.nlm.nih.gov/pubmed/31388351
http://dx.doi.org/10.1186/s13027-019-0236-7
work_keys_str_mv AT hammerllucia theburdenofburkittlymphomainafrica
AT colombetmurielle theburdenofburkittlymphomainafrica
AT rochfordrosemary theburdenofburkittlymphomainafrica
AT ogwangdavidmartin theburdenofburkittlymphomainafrica
AT parkindonaldmaxwell theburdenofburkittlymphomainafrica
AT hammerllucia burdenofburkittlymphomainafrica
AT colombetmurielle burdenofburkittlymphomainafrica
AT rochfordrosemary burdenofburkittlymphomainafrica
AT ogwangdavidmartin burdenofburkittlymphomainafrica
AT parkindonaldmaxwell burdenofburkittlymphomainafrica